Work Package 5: Production Scale-up & Pre-clinical Development of Compounds

The primary aims of this work package are to take forward bioactive compounds identified from WP3 and WP4 and to evaluate their potential as new drug leads or ingredients for nutrition/cosmetic applications including upscaling and optimisation of the fermentation process beyond 1 L to 20 L.